The Leadership Team at FibroGen is responsible for strategic decision-making and oversight of the company's development and commercialization efforts. This multi-disciplinary group collaborates to guide the company's innovative pipeline of therapeutics in fibrosis, anemia, and cancer, ensuring alignment between clinical development, regulatory affairs, intellectual property, and operational management. Their leadership fosters a cohesive environment that drives the advancement of FibroGen's mission to deliver first-in-class therapies to patients.
Christine L. Chung
SVP, China Operations
Elias Kouchakji
SVP, Clinical Development, Dru...
Leanne C. Price
Chief Intellectual Property Of...
Michael D. Lowenstei...
Chief Legal Officer
Michael J. Martinell...
SVP, Technical Development
Pat Cotroneo
CFO
Percy H. Carter
Chief Scientific Officer
R. Wayne Frost
SVP, Regulatory Affairs
Richard Farley
VP, Human Resources
Thane Wettig
Chief Executive Officer
View all